S100A2 and neoplasm: EGF-stimulated EGFR phosphorylation induces the S100A2 expression, and S100A2 exhibits antitumor activity by reducing the rate of tumor growth when overexpressed in nude mice with NCI-H2172 cell tumor xenograft model [71].